REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinica Sugal S.A. (CLISUGALSA) (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Clinica Sugal S.A. (CLISUGALSA) Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Clinica Sugal S.A. (CLISUGALSA) is a company based in Ecuador, with its head office in Guayaquil. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on April 30, 2004. The total number of employees is currently 8 (2023). The company’s latest financial report indicates a net sales revenue increase of 4.45% in 2023. There was a total growth of 2.71% in Clinica Sugal S.A. (CLISUGALSA)’s total assets over the same period. The enterprise’s net profit margin decreased by 0.93% in 2023.

Headquarters
Av Justino Cornejo, Jornagaso Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Clinica Sugal S.A. (CLISUGALSA) report to view the information.

Basic Information
Total Employees:
Purchase the Clinica Sugal S.A. (CLISUGALSA) report to view the information.
Outstanding Shares:
Purchase the Clinica Sugal S.A. (CLISUGALSA) report to view the information.
Registered Capital:
Purchase the Clinica Sugal S.A. (CLISUGALSA) report to view the information.
Incorporation Date:
April 30, 2004
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.93%
Purchase this report to view the information.
0.07%
Subsidiaries
Galpe S.A.
20%
Company Performance
Financial values in the chart are available after Clinica Sugal S.A. (CLISUGALSA) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
4.45%
Total operating revenue
4.45%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-26.39%
Total assets
2.71%
Total equity
1.65%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.93%
Return on Equity (ROE)
-0.62%
Quick Ratio
-5.34%
Cash Ratio
-7.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?